Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.31 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16702912 | 0.87 | DRD2 (0.31) | — | |
| SCHEMBL434808 | 0.85 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2AATMKDM4E | |
| SCHEMBL17184104 | 0.80 | MEN1 (0.33) | ALDH1A1MEN1KMT2AATMKDM4E | |
| SCHEMBL230414 | 0.76 | KDM4E (0.50) | ALDH1A1MEN1KMT2AKDM4EGAA | |
| SCHEMBL15226755 | 0.75 | MAPT (0.35) | ALDH1A1MEN1KMT2AATMKDM4E | |
| SCHEMBL163147 | 0.74 | GAA (0.38) | ALDH1A1MEN1KMT2AKDM4EGAA | |
| SCHEMBL162659 | 0.71 | ALDH1A1 (0.35) | ALDH1A1MEN1KMT2AATMKDM4E | |
| SCHEMBL31095442 | 0.71 | PARP1 (0.32) | — | |
| SCHEMBL2890469 | 0.69 | CHRNA1 (0.32) | ALDH1A1KDM1A | |
| SCHEMBL123283 | 0.67 | KDM1A (0.32) | ALDH1A1MEN1KMT2AATMKDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011134964-A1 | SYNERGISTIC ACTIVE SUBSTANCE COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2011-11-03 | — | — | WO | claimed |
| EP-2382865-A1 | Synergistic active agent compounds | Bayer CropScience AG (DE) | 2011-11-02 | — | — | EP | claimed |
| US-20170142970-A1 | BINARY FUNGICIDAL MIXTURES | BAYER CROPSCIENCE AG | 2017-05-25 | — | — | US | disclosed |
| WO-2011134964-A1 | SYNERGISTIC ACTIVE SUBSTANCE COMBINATIONS | BAYER CROPSCIENCE AG (DE) | 2011-11-03 | — | — | WO | disclosed |
| EP-2382865-A1 | Synergistic active agent compounds | Bayer CropScience AG (DE) | 2011-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170142970-A1 | BINARY FUNGICIDAL MIXTURES | BROX, CYP4X1, CYP51A1 | ALDH1A1 1833/4885MEN1 1245/4885KMT2A 1940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.